RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 95 filers reported holding RELAY THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,019,207 | -21.8% | 240,096 | +16.8% | 0.00% | 0.0% |
| Q2 2023 | $2,581,846 | -6.8% | 205,561 | +22.2% | 0.00% | -50.0% |
| Q1 2023 | $2,769,513 | +75.4% | 168,155 | +58.1% | 0.00% | +100.0% |
| Q4 2022 | $1,578,524 | -33.2% | 106,333 | +3.1% | 0.00% | -50.0% |
| Q3 2022 | $2,362,852 | +46.5% | 103,145 | +7.3% | 0.00% | +100.0% |
| Q2 2022 | $1,613,399 | -40.1% | 96,168 | +8.6% | 0.00% | -50.0% |
| Q1 2022 | $2,694,072 | +145.8% | 88,562 | +151.7% | 0.00% | +100.0% |
| Q4 2021 | $1,096,000 | +11.4% | 35,186 | +12.8% | 0.00% | 0.0% |
| Q3 2021 | $984,000 | -18.9% | 31,194 | -5.9% | 0.00% | 0.0% |
| Q2 2021 | $1,213,000 | +34.3% | 33,149 | +26.9% | 0.00% | 0.0% |
| Q1 2021 | $903,000 | +9.9% | 26,129 | +32.1% | 0.00% | 0.0% |
| Q4 2020 | $822,000 | +9.7% | 19,784 | +12.4% | 0.00% | 0.0% |
| Q3 2020 | $749,000 | – | 17,597 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |